Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 14:2022:1148191.
doi: 10.1155/2022/1148191. eCollection 2022.

Striatal Syntaxin 1A Is Associated with Development of Tourette Syndrome in an Iminodipropionitrile-Induced Animal Model

Affiliations

Striatal Syntaxin 1A Is Associated with Development of Tourette Syndrome in an Iminodipropionitrile-Induced Animal Model

Liu Yang et al. Dis Markers. .

Abstract

Tourette syndrome (TS) is a neurodevelopmental movement disorder characterized by multiple motor and vocal tics. In this study, we used a TS rat model induced by 3,3'-iminodipropionitrile (IDPN) and aimed to investigate the expression change of Syntaxin 1A (STX1A). Rats in the control group received intraperitoneal injection of normal saline, and TS rats were injected with IDPN (150 mg/kg/day). After 7 days of treatment, the stereotypic behaviors were assessed. Next, rats were sacrificed; brains were removed for RNA extraction and Western blotting analysis and fixed in 4% paraformaldehyde for immunofluorescence analysis. After 7 days of IDPN administration, stereotypic behaviors were successfully induced. The IDPN group exhibited more counts in biting, putting forepaws around mouth, licking, head twitching, shaking claws, body raising, and episodic utterance. The striatal STX1A mRNA, protein, and STX1A expression in striatal dopaminergic neurons were investigated. As expected, the total STX1A mRNA and protein levels were decreased in the TS model rats. In the striatal dopaminergic neurons, the IDPN group showed a slightly decreased STX1A/TH double positive area, but no statistical significance was found. Additionally, we assessed the expression of some genes closely related to STX1A, such as SNAP25, SY, and gephyrin, and no differences were found between the two groups. Together, reduced STX1A expression is associated with IDPN-induced TS development. Our findings suggested that decreased striatal STX1A expression is associated with the development of TS in the IDPN-induced rat model.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
STX1A is decreased in the striatum of tic disorder (TD) rats: (a) decreased mRNA level in the IDPN (model) group (n = 3); (b) decreased protein level of STX1A in the IDPN group (n = 3); (c) a slight decrease of the STX1A/TH double positive area in the IDPN group (n = 3, no statistical significance). P < 0.05.

Similar articles

Cited by

References

    1. Brander G., Isomura K., Chang Z., et al. Association of Tourette syndrome and chronic tic disorder with metabolic and cardiovascular disorders. JAMA Neurology . 2019;76(4):454–461. doi: 10.1001/jamaneurol.2018.4279. - DOI - PMC - PubMed
    1. Poulter C., Mills J. Tourette’s syndrome and tic disorders. Innov AiT . 2018;11(7):362–365. doi: 10.1177/1755738017740914. - DOI
    1. Deeb W., Malaty I. A., Mathews C. A. Tourette disorder and other tic disorders. Handbook of Clinical Neurology . 2019;165:123–153. doi: 10.1016/B978-0-444-64012-3.00008-3. - DOI - PubMed
    1. Ekinci O., Erkan Ekinci A. Neurological soft signs and clinical features of tic-related obsessive-compulsive disorder indicate a unique subtype. The Journal of Nervous and Mental Disease . 2020;208(1):21–27. doi: 10.1097/NMD.0000000000001098. - DOI - PubMed
    1. Essoe J. K., Grados M. A., Singer H. S., Myers N. S., McGuire J. F. Evidence-based treatment of Tourette's disorder and chronic tic disorders. Expert Review of Neurotherapeutics . 2019;19(11):1103–1115. doi: 10.1080/14737175.2019.1643236. - DOI - PubMed